Live feed07:00:00·55mPRReleasevia QuantisnowRezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital HyperinsulinismByQuantisnow·Wall Street's wire, on your screen.RZLT· Rezolute Inc.Health Care
